GoldenTree Asset Management LP has recently announced that it has increased stake in Bausch Health Companies Inc (NYSE:BHC) by 21.31%. After grabbing 20.06 million shares, the institutional investor is now in possession of 3.52 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 5.51% having worth around $164.86 million. Moreover, Franklin Advisers, Inc. increased its share by 40182.0 to have a control over 15.84 million shares. And National Bank Financial, Inc. raised its holdings to 2.48 million shares by acquiring 15.64 million shares or 4.29% of the stake.
Bausch Health Companies Inc (BHC) concluded trading on 11/16/23 at a closing price of $6.56, with 3.24 million shares of worth about $21.23 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -23.36% during that period and on Thursday the price saw a loss of about -5.48%. Currently the company’s common shares owned by public are about 361.90M shares, out of which, 357.30M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 8 analysts are covering the BHC stock and their offered price forecasts bring an average price target of $9.50. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $16.00 and could fall to a lowest price of $6.00. The stock’s current price level is 30.95% above of average price target set by the analysts, while a rise to estimated low would result in loss of -9.33% for the stock. However, touching the estimated high of $16.00 would mean a gain of 59.0% for the stock.
Franklin Income Fund, Vanguard Total International Stoc, and Government Pension Fund – Global are the top 3 mutual funds which are holding stakes in Bausch Health Companies Inc Franklin Income Fund is currently holding 15.0 million shares of worth totaling $123.3 million. The company recently came buying 0.0 shares which brought its stake up to 4.12% of the company’s outstanding shares. Vanguard Total International Stoc sold 23501.0 shares, after which its hold over company’s outstanding shares shrunk to 1.17%, leaving 4.26 million shares with the mutual fund that have a worth of about $35.03 million. Government Pension Fund – Global, after selling 3.22 million shares, have now control over 0.88% of the stake in the company. It holds -0.1 million shares of worth $26.47 million.
Bausch Health Companies Inc (NYSE: BHC) started trading at $6.92, below -$0.02 from concluding price of the previous day. However, the stock later moved at a day high price of 6.92, or with a loss of -5.48%. Stock saw a price change of -4.09% in past 5 days and over the past one month there was a price change of -15.46%. Year-to-date (YTD), BHC shares are showing a performance of 4.46% which decreased to -8.64% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.57 but also hit the highest price of $10.23 during that period. The average intraday trading volume for Bausch Health Companies Inc shares is 2.96 million. The stock is currently trading -6.51% below its 20-day simple moving average (SMA20), while that difference is down -14.44% for SMA50 and it goes to -17.24% lower than SMA200.
GoldenTree Asset Management LP acquired 20.06 million shares of Bausch Health Companies Inc having value of about $164.86 million. Data submitted at the U.S SEC by GoldenTree Asset Management LP revealed that the firm now holds 3.52 million shares in the company valued at close to $23112388.8, or have control over 21.31% stake in the company. Bausch Health Companies Inc (NYSE: BHC) currently have 361.90M outstanding shares and institutions hold larger chunk of about 78.25% of that. Holding of mutual funds in the company is about 14.24% while other institutional holders and individual stake holders have control over 61.28% and 13.76% of the stake respectively.
The stock has a current market capitalization of $2.40B and its 3Y-monthly beta is at 0.96. It has posted earnings per share of -$2.65 in the same period. It has Quick Ratio of 0.89. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BHC, volatility over the week remained 4.00% while standing at 4.33% over the month.
Analysts are in expectations that Bausch Health Companies Inc (BHC) stock would likely to be making an EPS of $The Kraft Heinz Company in the current quarter, while forecast for next quarter EPS is $33.81 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $BTC which is $BHP Group Limited at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $Bausch Health Companies Inc. in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 1.02% while it is estimated to increase by 13.07% in next year.
Analysts at 8 brokerage firms have issued recommendations for the Bausch Health Companies Inc (BHC)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.62. Out of those 8 Wall Street analysts, 2 recommended a “Buy” rating, while 5 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on September 20, 2023 offering a Buy rating for the stock and assigned a target price range of between $9 and $16 to it.
